Lexeo Therapeutics, Inc. [LXEO] - Lexeo Therapeutics / Mantle Therapeutics merger
Lexeo Therapeutics, Inc. has entered into a definitive merger agreement to acquire Mantle Therapeutics Inc. for a total upfront purchase price of $5.3 million in cash and $3 million in Lexeo common stock, with Mantle becoming a wholly owned subsidiary of Lexeo upon completion.
Why this matters
Generating analysis…